Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$546M |
| 2 |
Microsoft
MSFT
|
+$480M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$362M |
| 4 |
Meta Platforms (Facebook)
META
|
+$350M |
| 5 |
Coca-Cola
KO
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Robinhood
HOOD
|
+$1.04B |
| 2 |
Palantir
PLTR
|
+$800M |
| 3 |
Apple
AAPL
|
+$516M |
| 4 |
Netflix
NFLX
|
+$326M |
| 5 |
NVIDIA
NVDA
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.71% |
| 2 | Healthcare | 15.15% |
| 3 | Consumer Discretionary | 11.78% |
| 4 | Communication Services | 10.55% |
| 5 | Financials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SBFM
3276
Sunshine Biopharma
SBFM
$1.31M
| $83K | ﹤0.01% |
5,570
+161
| +3% | +$2.39K |
2025 Q2
1 quarter
|
|
|
BRNS
3277
DELISTED
Barinthus Biotherapeutics
BRNS
| $82.9K | ﹤0.01% |
66,300
+30,000
| +83% | +$37.5K |
2023 Q1
10 quarters
|
|
|
OKYO
3278
OKYO Pharma
OKYO
$74.5M
| $82.4K | ﹤0.01% |
+41,200
| New | +$105K |
2025 Q3
0 quarters
|
|
3279
Ascent Solar Technologies
ASTI
$21.5M
| $82K | ﹤0.01% |
+41,818
| New | +$85K |
2025 Q3
0 quarters
|
|
3280
Beamr Imaging
BMR
$27.5M
| $81.7K | ﹤0.01% |
+26,700
| New | +$81.6K |
2025 Q3
0 quarters
|
|
|
STG
3281
Sunlands Technology
STG
$34.2M
| $80.8K | ﹤0.01% |
+10,098
| New | +$92.4K |
2025 Q3
0 quarters
|
|
|
CARM
3282
DELISTED
Carisma Therapeutics
CARM
| $80.5K | ﹤0.01% |
293,686
-35,600
| -11% | -$11.8K |
2022 Q1
14 quarters
|
|
|
HUHU
3283
HUHUTECH International Group
HUHU
$78.8M
| $80.2K | ﹤0.01% |
+15,600
| New | +$102K |
2025 Q3
0 quarters
|
|
|
RVPH
3284
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $79.8K | ﹤0.01% |
+10,830
| New | +$92K |
2025 Q3
0 quarters
|
|
3285
Oriental Culture Holding
OCG
$3.57M
| $78.6K | ﹤0.01% |
32
-6
| -16% | -$18K |
2021 Q3
16 quarters
|
|
3286
Siebert Financial
SIEB
$92.9M
| $78.5K | ﹤0.01% |
26,900
+4,900
| +22% | +$16.9K |
2024 Q2
5 quarters
|
|
3287
Drilling Tools International
DTI
$72.3M
| $78.5K | ﹤0.01% |
34,111
+24,071
| +240% | +$52.9K |
2024 Q3
4 quarters
|
|
|
IMDX
3288
Insight Molecular Diagnostics
IMDX
$110M
| $78.4K | ﹤0.01% |
23,600
-2,500
| -10% | -$7.05K |
2025 Q2
1 quarter
|
|
3289
PharmaCyte Biotech
PMCB
$4.34M
| $77.6K | ﹤0.01% |
80,000
+30,200
| +61% | +$30.1K |
2023 Q2
9 quarters
|
|
3290
Lightwave Logic
LWLG
$766M
| $76.5K | ﹤0.01% |
20,607
-2,993
| -13% | -$7.72K |
2025 Q2
1 quarter
|
|
|
TEAD
3291
Teads Holding Co
TEAD
$53.3M
| $76.2K | ﹤0.01% |
46,200
-49,800
| -52% | -$105K |
2022 Q1
14 quarters
|
|
3292
Eve Holding
EVEX
$582M
| $76.2K | ﹤0.01% |
+20,000
| New | +$106K |
2025 Q3
0 quarters
|
|
3293
Claros Mortgage Trust
CMTG
$169M
| $75.4K | ﹤0.01% |
+22,700
| New | +$76.4K |
2025 Q3
0 quarters
|
|
|
KORE
3294
DELISTED
KORE Group Holdings
KORE
| $74.9K | ﹤0.01% |
30,941
+2,300
| +8% | +$5.49K |
2022 Q2
13 quarters
|
|
|
ORGN
3295
DELISTED
Origin Materials
ORGN
| $73.6K | ﹤0.01% |
4,730
-12,237
| -72% | -$227K |
2024 Q3
4 quarters
|
|
|
IPM
3296
Intelligent Protection Management Corp
IPM
$23.1M
| $73K | ﹤0.01% |
36,700
+2,600
| +8% | +$5.16K |
2023 Q3
8 quarters
|
|
|
CASI
3297
DELISTED
CASI Pharmaceuticals
CASI
| $72.9K | ﹤0.01% |
43,900
+4,700
| +12% | +$8.38K |
2022 Q3
12 quarters
|
|
|
GCL
3298
GCL Global Holdings
GCL
$101M
| $72.5K | ﹤0.01% |
+28,900
| New | +$97.3K |
2025 Q3
0 quarters
|
|
|
ANEB
3299
DELISTED
Anebulo Pharmaceuticals
ANEB
| $71.3K | ﹤0.01% |
+28,500
| New | +$67.1K |
2025 Q3
0 quarters
|
|
3300
Wah Fu Education Group
WAFU
$6.4M
| $71.2K | ﹤0.01% |
38,700
+16,800
| +77% | +$25.6K |
2025 Q1
2 quarters
|
|
Similar funds
Renaissance Technologies's Q3 2025 Portfolio in Review
As of Q3 2025, Renaissance Technologies held 4,038 positions worth $75.8B, up 0.77% from $75.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies withdrew a net $5.41B in Q3 2025, closing 581 positions and reducing 1,457 holdings. Its most notable exit was GE Aerospace, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Alphabet (Google) Class C worth $419M.
- Renaissance Technologies's largest Q3 2025 buy was Alphabet (Google) Class C: 1,720,002 shares worth $419M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2025, an estimated $546M increase.
- Renaissance Technologies's biggest Q3 2025 reduction was Robinhood, cutting an estimated $1.04B.
- Renaissance Technologies fully exited GE Aerospace in Q3 2025, selling an estimated $235M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.8B portfolio in Q3 2025.
- Renaissance Technologies opened 515 new positions and closed 581 in Q3 2025.
- Renaissance Technologies's portfolio value rose 0.77% quarter-over-quarter to $75.8B.
Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.